干细胞移植治疗骨质疏松

被引:5
作者
王强
赵兵
李超
陶天遵
机构
[1] 哈尔滨医科大学第二附属医院骨二科
关键词
骨质疏松; 骨髓间充质干细胞; 干细胞移植;
D O I
暂无
中图分类号
R580 [];
学科分类号
1002 ; 100201 ;
摘要
目前治疗原发性骨质疏松症的药物主要作用于骨形成和骨吸收耦联失调,而对骨髓间充质干细胞(MSCs)与骨质疏松关联的治疗方法尚未研制成功。骨髓间充质干细胞的衰老是原发性骨质疏松症的发病机制之一。间充质干细胞衰老,导致干细胞增殖能力下降,成骨分化能力减弱,成脂分化增强,骨组织成分减少,骨矿物质基质减少,脂肪组织增加,最终导致骨量减少,骨纤维结构异常,进而出现骨质疏松。移植自体、同种异体的MSCs或者基因修饰MSCs可以有效增加局部骨量,提高骨密度,增强骨力学强度,改善局部骨质疏松情况,可纠正骨代谢失衡,减少骨量丢失,增加成骨,有望为治疗骨质疏松提供一种新的策略和方法。
引用
收藏
页码:225 / 229
页数:5
相关论文
共 14 条
[2]   基因修饰骨髓间充质干细胞复合珊瑚羟基磷灰石支架材料修复骨质疏松性下颌骨缺损 [J].
唐尤超 ;
王远勤 ;
汤炜 .
中国组织工程研究与临床康复, 2008, (14) :2601-2605
[3]   Telomerase-Deficient Mice Exhibit Bone Loss Owing to Defects in Osteoblasts and Increased Osteoclastogenesis by Inflammatory Microenvironment [J].
Saeed, Hamid ;
Abdallah, Basem M. ;
Ditzel, Nicholas ;
Catala-Lehnen, Philip ;
Qiu, Weimin ;
Amling, Michael ;
Kassem, Moustapha .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1494-1505
[4]   Bone Repair by Transplantation of hTERT-Immortalized Human Mesenchymal Stem Cells in Mice [J].
Nakahara, Hiroyuki ;
Misawa, Haruo ;
Hayashi, Takahiro ;
Kondo, Eisaku ;
Yuasa, Takeshi ;
Kubota, Yasuhiro ;
Seita, Masayuki ;
Kawamoto, Hironobu ;
Hassan, Wael A. R. A. ;
Hassan, Reham A. R. A. ;
Javed, Shahid M. ;
Tanaka, Masato ;
Endo, Hirosuke ;
Noguchi, Hirofumi ;
Matsumoto, Shinichi ;
Takata, Katsuyoshi ;
Tashiro, Yuichi ;
Nakaji, Shuhei ;
Ozaki, Toshifumi ;
Kobayashi, Naoya .
TRANSPLANTATION, 2009, 88 (03) :346-353
[5]   Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients [J].
Coipeau, Patrick ;
Rosset, Philippe ;
Langonne, Alain ;
Gaillard, Julien ;
Delorme, Bruno ;
Rico, Angelique ;
Domenech, Jorge ;
Charbord, Pierre ;
Sensebe, Luc .
CYTOTHERAPY, 2009, 11 (05) :584-594
[6]   Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells [J].
Zhao, Yan-Min ;
Li, Jing-Yuan ;
Lan, Jian-Ping ;
Lai, Xiao-Yu ;
Luo, Yi ;
Sun, Jie ;
Yu, Jian ;
Zhu, Yuan-Yuan ;
Zeng, Fen-Fang ;
Zhou, Qian ;
Huang, He .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 369 (04) :1114-1119
[7]  
Increased adipogenesis of osteoporotic human‐mesenchymal stem cells (MSCs) characterizes by impaired leptin action[J] . PabloAstudillo,SusanaRíos,LuisPastenes,Ana MaríaPino,J. PabloRodríguez.J. Cell. Biochem. . 2008 (4)
[8]   Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts [J].
Zhou, Shuanhu ;
Greenberger, Joel S. ;
Epperly, Michael W. ;
Goff, Julie P. ;
Adler, Carolyn ;
LeBoff, Meryl S. ;
Glowacki, Julie .
AGING CELL, 2008, 7 (03) :335-343
[9]  
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute[J] . M.E.Bernardo,M.A.Avanzini,C.Perotti,A.M.Cometa,A.Moretta,E.Lenta,C.Del Fante,F.Novara,A.de Silvestri,G.Amendola,O.Zuffardi,R.Maccario,F.Locatelli.J. Cell. Physiol. . 2007 (1)
[10]  
Cell Therapy: A Therapeutic Alternative to Treat Focal Cartilage Lesions[J] . M.J. Gimeno,E. Maneiro,E. Rendal,M. Ramallal,L. Sanjurjo,F.J. Blanco.Transplantation Proceedings . 2005 (9)